New

Asia Pacific Ocular Drug Delivery Market

2021

Asia Pacific Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)

Publication Month: Nov 2021 | Report Code: TIPRE00025781 | No. of Pages: 145 | Category: Pharmaceuticals | Status: Published

Market Insights

Asia Pacific Ocular Drug Delivery Market to Grow at a CAGR of 8.2% to reach US$ 5,608.56 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The ocular drug delivery market in Asia Pacific is expected to grow toUS$ 5,608.56 million by 2028 from US$ 3,234.93 million in 2021. The market is estimated to grow at a CAGR of 8.2% from 2021 to 2028.


Several players operating in the ocular drug delivery market are developing and launching innovative products. The strategy of development and launch of new products helps companies to cater to a broad customer base. For instance, in June 2020, Senju Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. announced the launch of a new combination ophthalmic solution, AILAMIDE Combination Ophthalmic Suspension, for the treatment of glaucoma and ocular hypertension. Additionally, in May 2019, Menicon Co., Ltd launched Menicon Bloom Myopia Control Management System. Menicon Bloom Night therapy includes the overnight wearing of a specifically designed reverse geometry orthokeratology contact lens—manufactured in hyper oxygen-permeable Menicon Z rigid material that guarantees ideal corneal oxygenation for comfortable contact lens wear. Such developments and launches of new products are emerging as a key trend in the ocular drug delivery market.

The 2019 novel coronavirus (2019-nCoV), officially named COVID-19 by the WHO, has spread to more than 170 countries, including China prompting the WHO to declare the disease as a global pandemic. COVID-19 has had a tremendous impact on eye care delivery across the Asia Pacific region. In Bangladesh, all routine elective eye surgeries were postponed. Only emergency eye treatment was conducted only at outpatient departments. Moreover, patients were allowed to go to hospital only in the case of emergency. Similarly in India, outreach eye health services stopped largely thus impacting the rural communities. All elective surgeries were postponed. Non-cataract conditions like diabetic retinopathy and glaucoma patients affected due to break in follow-ups. Additionally, COVID-19 is having a tremendous impact on eye care in the Maldives. Due to the lock down people are not able to travel from one place to the other. Air and sea transport is at standstill and people from the outlying islands are not able to visit the nearest centre for eye care. A few centers in the capital Male are offering online consultations to patients. However, this has its limitations and healthcare professionals cannot do refractions online and a detailed anterior segment and posterior segment examinations is also not possible. Thus, COVID 19 is having a significant impact on the quality and quantity of eye care in the Maldives.

With the new features and technologies, companies can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the ocular drug delivery market. The Asia Pacific ocular drug delivery market is expected to grow at a good CAGR during the forecast period.

Get more information on this report :


Asia Pacific Ocular Drug Delivery Market Segmentation

Asia Pacific Ocular Drug Delivery Market – By Technology

  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System
  • Others

Asia Pacific Ocular Drug Delivery Market – By Formulation Type

  • Solution
  • Ointment
  • Suspension
  • Emulsion
  • Liposomes and Nanoparticles

Asia Pacific Ocular Drug Delivery Market – By Disease type

  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Glaucoma
  • Diabetic Retinopathy
  • Diabetic Macular Edema
  • Others

Asia Pacific Ocular Drug Delivery Market – By End User

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

Asia Pacific Ocular Drug Delivery Market – By Country

  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Rest of APAC

Asia Pacific Ocular Drug Delivery Market – Companies Mentioned

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Clearside Biomedical, Inc
  • Taiwan Liposome Company, Ltd.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Ocular Drug Delivery Market – By Technology

1.3.2 Asia Pacific Ocular Drug Delivery Market – By Formulation Type

1.3.3 Asia Pacific Ocular Drug Delivery Market – By Disease Type

1.3.4 Asia Pacific Ocular Drug Delivery Market – By End User

1.3.5 Asia Pacific Ocular Drug Delivery Market – By Country

2. Asia Pacific Ocular Drug Delivery Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Ocular Drug Delivery – Market Landscape

4.1 Overview

4.2 Expert Opinions

5. Asia Pacific Ocular Drug Delivery Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Burgeoning Prevalence of Eye Disorders

5.1.2 Accelerated Research on Ocular Drug Delivery

5.2 Market Restraints

5.2.1 Difficulties Associated with Ocular Drug Delivery

5.3 Market Opportunities

5.3.1 Boosting Awareness About Vision Care

5.4 Future Trends

5.4.1 Rise of Innovative Products

5.5 Impact analysis

6. Asia Pacific Ocular Drug Delivery – Market Analysis

6.1 Asia Pacific Ocular Drug Delivery Market Revenue Forecast and Analysis

7. Asia Pacific Ocular Drug Delivery Market Analysis – By Technology

7.1 Overview

7.2 Asia Pacific Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3 Implantable Ocular Drug Delivery Systems

7.3.1 Overview

7.3.2 Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4 Particulate Drug Delivery Systems

7.4.1 Overview

7.4.2 Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5 Nano-Particle Drug Delivery System

7.5.1 Overview

7.5.2 Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Ocular Drug Delivery Market Analysis – By Formulation Type

8.1 Overview

8.1.1 Asia Pacific Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2 Liposomes and Nanoparticles Market

8.2.1 Overview

8.2.2 Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3 Solution

8.3.1 Overview

8.3.2 Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Emulsion

8.4.1 Overview

8.4.2 Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5 Suspension

8.5.1 Overview

8.5.2 Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6 Ointment

8.6.1 Overview

8.6.2 Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9. Asia Pacific Ocular Drug Delivery Market Analysis – By Disease Type

9.1 Overview

9.2 Asia Pacific Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3 Cataract

9.3.1 Overview

9.3.2 Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4 Dry Eye Syndrome

9.4.1 Overview

9.4.2 Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5 Macular Degeneration

9.5.1 Overview

9.5.2 Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6 Glaucoma

9.6.1 Overview

9.6.2 Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7 Diabetic Retinopathy

9.7.1 Overview

9.7.2 Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8 Diabetic Macular Edema

9.8.1 Overview

9.8.2 Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Ocular Drug Delivery Market Analysis – By End User

10.1 Overview

10.2 Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Ophthalmic Clinics

10.4.1 Overview

10.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5 Ambulatory Surgical Centers

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11. Asia Pacific Ocular Drug Delivery Market – Country Analysis

11.1 Overview

11.1.1 Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

11.1.1.1 China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1 China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.2 China: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.1.3 China: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.1.4 China: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.1.5 China: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.2 Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1 Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.2 Japan: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.2.3 Japan: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.2.4 Japan: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.2.5 Japan: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.3 India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1 India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.2 India: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.3.3 India: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.3.4 India: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.3.5 India: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.4 Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.4.1 Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.4.2 Australia: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.4.3 Australia: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.4.4 Australia: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.4.5 Australia: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.5 South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.5.1 South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.5.2 South Korea: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.5.3 South Korea: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.5.4 South Korea: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.5.5 South Korea: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.6 Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.6.1 Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.6.2 Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.6.3 Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.6.4 Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.6.5 Rest of Asia Pacific: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Asia Pacific Ocular Drug Delivery Market

12.1 Impact Assessment of COVID-19 Pandemic

13. Industry Landscape

13.1 Overview

13.2 Organic Developments

13.2.1 Overview

13.3 Inorganic Developments

13.3.1 Overview

14. Company Profiles

14.1 AbbVie Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bausch Health Companies Inc.

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Taiwan Liposome Company, Ltd.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Novartis AG

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Clearside Biomedical, Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. China: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 2. China: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 4. China: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5. Japan: Ocular Drug Delivery Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 6. Japan: Ocular Drug Delivery Market, By Formulation Type– Revenue and Forecast to 2028 (USD Million)

Table 7. Japan: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Japan: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. India: Ocular Drug Delivery Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 10. India: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 11. India: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 12. India: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13. Australia: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 14. Australia: Ocular Drug Delivery Market, By Formulation Type– Revenue and Forecast to 2028 (USD Million)

Table 15. Australia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 16. Australia: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. South Korea: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 18. South Korea: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 19. South Korea: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 20. South Korea: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type– Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of Asia Pacific: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25. Organic Developments Done By Companies

Table 26. Inorganic Developments Done by Companies

Table 27. Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1. Asia Pacific Ocular Drug Delivery Market Segmentation

Figure 2. Asia Pacific Ocular Drug Delivery Market Segmentation, By Country

Figure 3. Asia Pacific Ocular Drug Delivery Market Overview

Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5. Japan to Show Significant Growth During Forecast Period

Figure 6. Asia Pacific Ocular Drug Delivery Market, Industry Landscape

Figure 7. Asia Pacific PEST Analysis

Figure 8. Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9. Asia Pacific Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10. Asia Pacific Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11. Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Asia Pacific Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16. Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Asia Pacific Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22. Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29. Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33. Asia Pacific: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (USD Million)

Figure 34. Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

Figure 35. China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 36. Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 37. India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  1. AbbVie Inc.                                              
  2. Bausch Health Companies Inc.            
  3. Novartis AG                                            
  4. Clearside Biomedical, Inc.
  5. Taiwan Liposome Company, Ltd.        
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific ocular drug delivery market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
TIPRE00025781
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.